Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
about
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksOstracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder--was this a correct decision? A literature reviewStatic magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.Hydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway.8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases.From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?Superior working memory and behavioural habituation but diminished psychomotor coordination in mice lacking the ecto-5'-nucleotidase (CD73) gene.Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction.Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.How does adenosine control neuronal dysfunction and neurodegeneration?Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.Early adenosine release contributes to hypoxia-induced disruption of stimulus-induced sharp wave-ripple complexes in rat hippocampal area CA3.Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI.Effects of ethanolic extract and naphthoquinones obtained from the bulbs of Cipura paludosa on short-term and long-term memory: involvement of adenosine A₁ and A₂A receptors.A study of the possible association between adenosine A2A receptor gene polymorphisms and attention-deficit hyperactivity disorder traits.Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.Synthesis and properties of a new water-soluble prodrug of the adenosine A 2A receptor antagonist MSX-2.The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system.Caffeine treatment prevents rapid eye movement sleep deprivation-induced impairment of late-phase long-term potentiation in the dentate gyrus.Profile of nucleotide catabolism and ectonucleotidase expression from the hippocampi of neonatal rats after caffeine exposure.Therapeutics of Neurotransmitters in Alzheimer's Disease.Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A1 Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility
P2860
Q26740559-EBA0BE64-19D2-4EF9-B82B-24181D5D06CAQ28243209-84A10166-0C3C-45CB-8E07-4E610F50F1A5Q28476027-40733A69-13C4-487D-BC65-32CADDFA8648Q34238362-82CCEBE5-47B9-4EDA-B8BB-9C5E18A1C5F0Q35046370-998E5C9F-6869-4BAD-8E1B-66787291C486Q35093638-0987431D-A01B-41A1-827C-EB498A7A2C34Q35166780-A2E25721-9C8F-4CB5-BA2D-61B833E8F7FEQ35634105-2F726C4A-F3E7-477B-A402-FCDB283DADB0Q36821543-2E898363-6130-40AC-B62B-8B36EC97A8B5Q37298281-0A637590-9780-4038-B62F-C55945D10C6AQ37627259-55255537-DF39-4352-A8DA-5AEF4CD552A5Q38200930-C1001DD4-1A5F-46DB-995F-0610C83A5CE2Q38765118-83676FFB-A442-41AE-876B-545878B30FB4Q38882782-EC2E98C8-43B6-4A15-8CD1-EB92399F14E7Q39432789-674613AB-47B7-420B-BF3D-713220B578C7Q40955600-6EB3AE8B-A531-4336-8665-015B2862A243Q42656092-1A3ABFA7-DE0E-4016-9639-A4136C8ACC84Q43682039-048F8FE7-28E9-4891-8C77-7CC74BF3DADCQ44329637-06CFE308-807C-4793-847C-1F4D4E2A7673Q45341017-D209AF43-2812-41E1-8531-5DA0EC594714Q46729445-6436382B-E7E4-4A63-AB06-0434674F5439Q47723787-EE54C09E-850B-48D4-B6FB-6DA022493A67Q47928716-F8F0D809-C66C-45BF-9FB7-DC4BCC9337E2Q48949104-31653691-6C28-4F9C-888D-42C121F8962BQ49672905-88A2499A-3E9E-4541-923E-FA8CE6E080BFQ58855712-81F16D74-552E-4298-865C-DE204065FCA7
P2860
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@ast
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@en
type
label
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@ast
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@en
prefLabel
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@ast
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@en
P356
P1476
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
@en
P2093
Reinaldo Naoto Takahashi
P356
10.2741/2870
P577
2008-01-01T00:00:00Z